ArticleInternational journal of hematology-oncology and stem cell research2025
ESHAP versus IEV Chemotherapy for Relapsed or Refractory Hodgkin's and Non-Hodgkin's Lymphoma.
Mehdi Dehghani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.